Circio at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Circio brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on a DNA vector platform that produces circular RNA inside cells to make gene therapy expression stronger and longer lasting. Applications covered include T cell therapies and cardiac expression at a lower AAV dose.
| Organization | ESGCT 2026 Attendance |
|---|---|
Develops circular RNA technology, including the circVec DNA vector platform, to strengthen gene therapy expression, plus immunotherapy programs. | Talk Wed Oct 28 10:00am–10:30am circVec: A DNA Vector Platform Harnessing Intracellular Circular RNA Biogenesis for Next-Generation T Cell Therapies Vectors and delivery (AAV, lentiviral, LNP)Cell therapies and CAR-T Poster Wed Oct 28 1:30pm–3:30pm circVec Reduces AAV Vector Dose Through Durable and Potent Circular RNA Expression Poster Thu Oct 29 2:00pm–4:00pm AAV-circVec Enhances Cardiac Expression While Minimizing Dose and Cellular Stress |
Instantly find 20 buyers from Circio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction